Recurrent chronic conjunctival erosions secondary to cabozantanib. Youhnovska E, Pollmann AS, Blais N, Robert MC, et al. Can J Ophthalmol 2024 Nov 23:S0008-4182(24)00342.

Read + Share

Amedeo Smart

Independent Medical Education

Youhnovska E, Pollmann AS, Blais N, Robert MC, et al. Recurrent chronic conjunctival erosions secondary to cabozantanib. Can J Ophthalmol 2024 Nov 23:S0008-4182(24)00342.
PMID: 39592093